Finance

DNA2.0 Inc. receives NSF grant to optimize genes for protein production

Published in Lab Business Week, January 14th, 2007

DNA2.0, Inc., a leader in synthetic biology and the largest U.S. provider of synthetic genes, has been awarded an SBIR/NSF grant to further expand their expertise in protein expression and to develop an automated multivariate machine learning algorithm for optimizing synthetic gene design.

Recombinant DNA technologies launched the biotechnology industry by allowing cost-effective production of valuable therapeutic proteins in easily cultured and manipulated organisms. Despite the early success of biotechnology, protein expression of recombinant genes remains a key limiting step.

Efficient gene synthesis technology allows the complete redesign of any...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-01-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry